Pregled bibliografske jedinice broj: 1111109
Mutations inRIT1cause Noonan syndrome - additional functional evidence and expanding the clinical phenotype
Mutations inRIT1cause Noonan syndrome - additional functional evidence and expanding the clinical phenotype // Clinical Genetics, 89 (2015), 3; 359-366 doi:10.1111/cge.12608 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1111109 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Mutations inRIT1cause Noonan syndrome - additional functional evidence and expanding the clinical phenotype
Autori
Koenighofer, M. ; Hung, C. Y. ; McCauley, J. L. ; Dallman, J. ; Back, E. J. ; Mihalek, I. ; Gripp, K. W. ; Sol-Church, K. ; Rusconi, P. ; Zhang, Z. ; Shi, G-X. ; Andres, D. A. ; Bodamer, O. A.
Izvornik
Clinical Genetics (0009-9163) 89
(2015), 3;
359-366
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
RIT1, Noonan syndrom, genotype-phenotype correlation
Sažetak
RASopathies are a clinically heterogeneous group of conditions caused by mutations in 1 of 16 proteins in the RAS‐mitogen activated protein kinase (RAS‐MAPK) pathway. Recently, mutations in RIT1 were identified as a novel cause for Noonan syndrome. Here we provide additional functional evidence for a causal role of RIT1 mutations and expand the associated phenotypic spectrum. We identified two de novo missense variants p.Met90Ile and p.Ala57Gly. Both variants resulted in increased MEK‐ERK signaling compared to wild‐type, underscoring gain‐of‐function as the primary functional mechanism. Introduction of p.Met90Ile and p.Ala57Gly into zebrafish embryos reproduced not only aspects of the human phenotype but also revealed abnormalities of eye development, emphasizing the importance of RIT1 for spatial and temporal organization of the growing organism. In addition, we observed severe lymphedema of the lower extremity and genitalia in one patient. We provide additional evidence for a causal relationship between pathogenic mutations in RIT1, increased RAS‐MAPK/MEK‐ERK signaling and the clinical phenotype. The mutant RIT1 protein may possess reduced GTPase activity or a diminished ability to interact with cellular GTPase activating proteins ; however the precise mechanism remains unknown. The phenotypic spectrum is likely to expand and includes lymphedema of the lower extremities in addition to nuchal hygroma.
Izvorni jezik
Engleski
Znanstvena područja
Biologija, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE